Canadian Solar Inc. (CSIQ) Financials Nov 20, 2014, 7:27
Canadian Solar Inc. (CSIQ) Financials Nov 20, 2014, 7:27 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Canadian Solar Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 630.96M 1.5B 1.9B 1.29B 1.65B
Cost of Goods Sold (COGS) incl. D&A 552.86M 1.27B 1.72B 1.2B 1.38B
COGS excluding D&A 532.35M 1.24B 1.66B 1.12B 1.3B
Depreciation & Amortization Expense 20.51M 31.27M 56.12M 81.4M 80.82M
Depreciation 20.39M 30.95M 55.1M 80.64M 79.73M
Amortization of Intangibles - - 1.01M 754,148 1.09M
Gross Income 78.11M 228.77M 182.28M 90.36M 275.69M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 71.59M 108.47M 175.45M 227.43M 144.88M
Research & Development 3.18M 6.84M 19.84M 13M 11.68M
Other SG&A 68.41M 101.63M 155.61M 214.43M 133.19M
Other Operating Expense 0 0 0 0 (285)
Unusual Expense (9.87M) (1.66M) 5.75M 5.45M (10.76M)
EBIT after Unusual Expense 9.87M 1.66M (5.75M) (5.45M) 10.76M
Non Operating Income/Expense 7.68M (36.29M) (40.01M) (16.16M) (51.04M)
Non-Operating Interest Income 6.87M 4.08M 8.41M 13.36M 11.97M
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 9.46M 22.16M 43.84M 53.3M 46.24M
Gross Interest Expense 10.77M 23.85M 47.94M 58.61M 63.89M
Interest Capitalized 1.31M 1.69M 4.1M 5.3M 17.64M
Pretax Income 21.48M 67.58M (74.36M) (198.62M) 56.27M
Income Tax (1.3M) 16.75M 16.54M (5.43M) 7.64M
Income Tax - Current Domestic 4.79M 13.79M 8.05M 2.45M -
Income Tax - Current Foreign 5.61M 9.56M 13.08M 13.25M -
Income Tax - Deferred Domestic (8.49M) (5.76M) 2.58M 1.71M -
Income Tax - Deferred Foreign (3.21M) (848,566) (7.16M) (22.84M) -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 (1.97M) (3.06M)
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income 22.78M 50.83M (90.9M) (195.16M) 45.56M
Minority Interest Expense 132,315 259,477 (99,174) 313,594 13.91M
Net Income 22.65M 50.57M (90.8M) (195.47M) 31.66M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 22.65M 50.57M (90.8M) (195.47M) 31.66M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 22.65M 50.57M (90.8M) (195.47M) 31.66M
EPS (Basic) 0.61 1.18 (2.11) (4.53) 0.68
Basic Shares Outstanding 37.14M 42.84M 43.08M 43.19M 46.31M
EPS (Diluted) 0.60 1.16 (2.11) (4.53) 0.63
Diluted Shares Outstanding 37.73M 43.68M 43.08M 43.19M 50.39M
EBITDA 27.02M 151.57M 62.95M (55.67M) 211.64M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...
Continue Reading
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...
Continue Reading
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue Reading
Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...
Continue Reading
Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...
Continue Reading
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...
Continue Reading
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading
Top 5 Most Recently Viewed Articles
Viatris Launches Cash Tender Offers for Outstanding Notes Viatris Inc. (NASDAQ: VTRS), a leading player in the global healthcare sector, has initiated tender offers to acquire certain outstanding notes. This move is designed to strengthen its financial framework and enhance returns for its shareholders. Notably, the offers include various senior notes that were originally...
Continue Reading
Coke Florida Kicks Off Holiday Spirit with Caravan Tour Coca-Cola Beverages Florida, LLC (Coke Florida) is thrilled to share that its beloved annual "Holiday Caravan" is set to return. This event, which has become an essential part of the holiday season, features the iconic Coca-Cola red delivery truck decked out in festive cheer. Families will enjoy complimentary samples...
Continue Reading
Nexxen's Upcoming Participation at RBC Global Conference Nexxen International Ltd. (AIM/NASDAQ: NEXN), a leading global advertising technology platform, is geared up to take part in a significant event, the RBC Global Technology, Internet, Media and Telecommunications Conference. This event provides a stellar opportunity for companies to connect with investors and share...
Continue Reading
GayVeterans.us Achieves 501(c)(3) Tax Exempt Status GayVeteransUS-Inc. has recently been granted 501(c)(3) tax-exempt status, marking a significant milestone for the organization. This designation enables supporters to make tax-deductible contributions, strengthening the community's ability to provide enhanced resources and support. The dedication of veteran volunteers...
Continue Reading
Virbac Enhances Its Offerings with Felanorm Acquisition Virbac has announced a significant acquisition that marks a pivotal moment in its commitment to improving the health and quality of life for senior cats. This globally recognized drug is aimed at treating feline hyperthyroidism, a condition that is becoming increasingly common in older cats. Understanding Feline...
Continue Reading